Drugs / UFT
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00625352 | Feb 2008 → Dec 2009 | non-small cell lung carcinoma | Ulsan University Hospital | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | UFT | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00625352 ↗ |
| Route | Oral | “UFT 400mg daily PO” NCT00625352 ↗ |